FR2813606B1 - Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques - Google Patents

Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques

Info

Publication number
FR2813606B1
FR2813606B1 FR0011207A FR0011207A FR2813606B1 FR 2813606 B1 FR2813606 B1 FR 2813606B1 FR 0011207 A FR0011207 A FR 0011207A FR 0011207 A FR0011207 A FR 0011207A FR 2813606 B1 FR2813606 B1 FR 2813606B1
Authority
FR
France
Prior art keywords
diagnostic
bard1
protein
trunked
therapeutic applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0011207A
Other languages
English (en)
French (fr)
Other versions
FR2813606A1 (fr
Inventor
Fabien Gautier
Jean Harb
Khaled Meflah
Finger Irmgard Irminger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Santé et de la Recherche Médicale
Original Assignee
Institut National de la Santé et de la Recherche Médicale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0011207A priority Critical patent/FR2813606B1/fr
Application filed by Institut National de la Santé et de la Recherche Médicale filed Critical Institut National de la Santé et de la Recherche Médicale
Priority to AT01967422T priority patent/ATE328082T1/de
Priority to EP01967422A priority patent/EP1313855B1/fr
Priority to US10/363,285 priority patent/US7566764B2/en
Priority to PCT/FR2001/002731 priority patent/WO2002018536A2/fr
Priority to JP2002524039A priority patent/JP4995399B2/ja
Priority to DE60120187T priority patent/DE60120187T2/de
Priority to CA2421258A priority patent/CA2421258C/fr
Publication of FR2813606A1 publication Critical patent/FR2813606A1/fr
Application granted granted Critical
Publication of FR2813606B1 publication Critical patent/FR2813606B1/fr
Priority to US12/489,893 priority patent/US20100016228A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR0011207A 2000-09-01 2000-09-01 Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques Expired - Fee Related FR2813606B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0011207A FR2813606B1 (fr) 2000-09-01 2000-09-01 Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques
EP01967422A EP1313855B1 (fr) 2000-09-01 2001-09-03 Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques
US10/363,285 US7566764B2 (en) 2000-09-01 2001-09-03 Truncated BARD1 protein, and its diagnostic and therapeutic uses
PCT/FR2001/002731 WO2002018536A2 (fr) 2000-09-01 2001-09-03 Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques
AT01967422T ATE328082T1 (de) 2000-09-01 2001-09-03 Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen
JP2002524039A JP4995399B2 (ja) 2000-09-01 2001-09-03 切断されたｂａｒｄ１タンパク質、並びにその診断上及び治療上の利用
DE60120187T DE60120187T2 (de) 2000-09-01 2001-09-03 Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen
CA2421258A CA2421258C (fr) 2000-09-01 2001-09-03 Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques
US12/489,893 US20100016228A1 (en) 2000-09-01 2009-06-23 Truncated bard1 protein, and its diagnostic and therapeutic uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0011207A FR2813606B1 (fr) 2000-09-01 2000-09-01 Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques

Publications (2)

Publication Number Publication Date
FR2813606A1 FR2813606A1 (fr) 2002-03-08
FR2813606B1 true FR2813606B1 (fr) 2004-04-30

Family

ID=8853916

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0011207A Expired - Fee Related FR2813606B1 (fr) 2000-09-01 2000-09-01 Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques

Country Status (8)

Country Link
US (2) US7566764B2 (enExample)
EP (1) EP1313855B1 (enExample)
JP (1) JP4995399B2 (enExample)
AT (1) ATE328082T1 (enExample)
CA (1) CA2421258C (enExample)
DE (1) DE60120187T2 (enExample)
FR (1) FR2813606B1 (enExample)
WO (1) WO2002018536A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2681360A1 (en) * 2007-04-02 2008-10-09 Universite De Geneve Deletion bearing bard1 isoforms and use thereof
SG10201506437PA (en) * 2010-08-17 2015-10-29 Univ Geneve BARD1 Isoforms in Lung and Colorectal Cancer and Use Thereof
MX2016005686A (es) 2013-10-31 2016-08-11 Regeneron Pharma Ensayo de union competitiva al ligando para detectar anticuerpos neutralizantes.
EP2871480A1 (en) * 2013-11-06 2015-05-13 Bard1Ag SA Lung Cancer Diagnosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4586697A (en) * 1996-09-20 1998-04-14 Board Of Regents, The University Of Texas System Compositions and methods comprising bard1 and other brca1 binding proteins
EP1179541B1 (en) * 1999-04-28 2004-06-16 Board Of Regents, The University Of Texas System Compositions and methods for cancer treatment by selectively inhibiting VEGF

Also Published As

Publication number Publication date
ATE328082T1 (de) 2006-06-15
JP2004518410A (ja) 2004-06-24
DE60120187D1 (de) 2006-07-06
EP1313855A2 (fr) 2003-05-28
DE60120187T2 (de) 2007-03-29
FR2813606A1 (fr) 2002-03-08
US7566764B2 (en) 2009-07-28
JP4995399B2 (ja) 2012-08-08
EP1313855B1 (fr) 2006-05-31
WO2002018536A3 (fr) 2003-01-03
US20040234959A1 (en) 2004-11-25
CA2421258A1 (fr) 2002-03-07
WO2002018536A2 (fr) 2002-03-07
US20100016228A1 (en) 2010-01-21
CA2421258C (fr) 2011-04-19

Similar Documents

Publication Publication Date Title
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
DE60138715D1 (de) Tnf-rezeptor-ähnliche moleküle und deren anwendungen
YU84903A (sh) Antitela koja blokiraju cripto i njihova upotreba
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
DE602004011770D1 (de) Fusionsproteine
WO2002008285A3 (en) Il-17 molecules and uses thereof
MXPA03001984A (es) Variantes de factor vii de coagulacion humano.
WO1997033996A3 (en) Human bikunin
GB0100551D0 (en) Protein
CY1112957T1 (el) Μη νευροτοξικοι παραγοντες, οι οποιοι ενεργοποιουν το πλασμινογονο για τη θεραπευτικη αγωγη εγκεφαλικου επεισοδιου
DE60139544D1 (de) Veränderte, fluoreszierende proteine
DK1536006T3 (da) Cancerantigener og anvendelse deraf
AUPP472398A0 (en) Protease susceptibility II
ATE310085T1 (de) Cyclin-e2 proteine und dafür kodierende gene
WO2004076614A3 (de) Humane nukleinsäuresequenzen aus prostatakarzinomen
BR0113099A (pt) Gene e proteìna relacionados com esquizofrenia
PL374550A1 (en) Il-17 like molecules and uses thereof
FR2804127B1 (fr) Gene srn1 implique dans le syndrome nephrotique cortico- resistant, proteine codee par ce gene et utilisations diagnostiques et therapeutiques
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
WO2001059120A3 (en) Il-17 like molecules and uses thereof
ATE328082T1 (de) Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen
EA200200319A1 (ru) Белок iren, его получение и использование
WO2004053117A3 (en) Serine protease
PT1267940E (pt) Compostos para direccionamento
WO2002000826A3 (fr) Nouveau polypeptide, proteine humaine de methylation d'adn, et polynucleotide codant ce polypeptide

Legal Events

Date Code Title Description
TQ Partial transmission of property
ST Notification of lapse

Effective date: 20060531